The humble aspirin has certainly seen its star rise and fall a few times in the medical research community. Long thought to be a safe and smart way to lower the risk of having a heart attack due to its blood-thinning abilities, in 2022 it was recommended by the US Preventive Services Health Force that healthy people over 60 avoid taking the drug, as its risk of increasing internal bleeding outweighed its minor effects on heart health.

Yet earlier this year, it was shown that frequent aspirin use resulted in a 13% reduction in ovarian cancer regardless of genetic predisposition to the disease. Conversely, another study released early this summer indicated that daily aspirin supplementation could increase anemia risk in older adults.